Investing in Quest Diagnostics (NYSE:DGX) Five Years Ago Would Have Delivered You a 66% Gain
Investing in Quest Diagnostics (NYSE:DGX) Five Years Ago Would Have Delivered You a 66% Gain
If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share price move up more than the market average. Unfortunately for shareholders, while the Quest Diagnostics Incorporated (NYSE:DGX) share price is up 50% in the last five years, that's less than the market return. Looking at the last year alone, the stock is up 16%.
如果你购买并长期持有一只股票,你希望能够获得利润。最好的情况是,你希望股价上涨超过市场平均水平。不幸的是,对于股东来说,Quest Diagnostics Incorporated (纽交所: DGX) 的股价在过去五年中上涨了50%,但低于市场回报。仅看过去一年,股票上涨了16%。
Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business.
现在值得更详细地了解该公司的基本面,因为这将帮助我们判断长期股东回报是否与基础业务的表现相匹配。
To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.
引用本杰明·格雷厄姆的话:短期内市场是一个投票机,但长期来看它是一个称重机。评估公司周边环境的情绪变化的一种有缺陷但合理的方法是将每股收益(EPS)与股价进行比较。
Over half a decade, Quest Diagnostics managed to grow its earnings per share at 7.5% a year. So the EPS growth rate is rather close to the annualized share price gain of 8% per year. Therefore one could conclude that sentiment towards the shares hasn't morphed very much. Indeed, it would appear the share price is reacting to the EPS.
在过去五年中,Quest Diagnostics的每股收益增长率达到了7.5%。因此,每年年化股价增长率为8%,可以得出结论,投资者对这些股票的情绪变化不大。事实上,股价似乎是对每股收益做出反应的。
You can see how EPS has changed over time in the image below (click on the chart to see the exact values).
您可以在下面的图片中查看每股收益如何随时间变化(单击图表以查看确切的价值)。
![1724842279106](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240828/43002007-0-76812652a0b017709c5b202764c1cc57.webp/bigjpg)
Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.
在购买或出售股票之前,我们始终建议对历史增长趋势进行仔细研究,可以在这里找到相关信息。
What About Dividends?
那么分红怎么样呢?
When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. As it happens, Quest Diagnostics' TSR for the last 5 years was 66%, which exceeds the share price return mentioned earlier. This is largely a result of its dividend payments!
在考虑投资回报时,重要的是区分总股东回报率(TSR)和股价回报率之间的差异。TSR是一种计算回报率时考虑到现金股利价值(假设任何获得的股利都被再投资)和任何折扣增资和剥离计算价值的方法。可以说,TSR更全面地反映了股票带来的回报。事实上,奎斯特诊疗在过去5年的TSR达到了66%,超过了前面提到的股价回报率。这在很大程度上是其股息支付的结果!
A Different Perspective
不同的观点
Quest Diagnostics provided a TSR of 19% over the last twelve months. Unfortunately this falls short of the market return. The silver lining is that the gain was actually better than the average annual return of 11% per year over five year. This could indicate that the company is winning over new investors, as it pursues its strategy. It's always interesting to track share price performance over the longer term. But to understand Quest Diagnostics better, we need to consider many other factors. For example, we've discovered 1 warning sign for Quest Diagnostics that you should be aware of before investing here.
奎斯特诊疗在过去12个月内提供了19%的TSR。不幸的是,这低于市场回报。好消息是,这个收益实际上比过去五年的平均年回报率11%要好。这可能表明,该公司在追求其策略时赢得了新的投资者。长期跟踪股价表现总是有趣的。但要更好地了解奎斯特诊疗,我们需要考虑许多其他因素。例如,在投资这里之前,我们发现了1个有关奎斯特诊疗的警示信号,您应该注意这一点。
Of course Quest Diagnostics may not be the best stock to buy. So you may wish to see this free collection of growth stocks.
当然,奎斯特诊疗可能不是最好的股票购买选择。所以您可能希望查看这个免费的成长股票集合。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
请注意,本文所引述的市场回报反映了目前在美国交易所上市的股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。